PNC Financial Services Group’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-611
| Closed | -$18.1K | – | 4861 |
|
|
2023
Q4 | $18.1K | Buy |
611
+46
| +8% | +$916 | ﹤0.01% | 3491 |
|
|
2023
Q3 | $8.97K | Buy |
565
+299
| +112% | +$4.97K | ﹤0.01% | 3803 |
|
|
2023
Q2 | $5.02K | Buy |
266
+59
| +29% | +$697 | ﹤0.01% | 4112 |
|
|
2023
Q1 | $795 | Hold |
207
| – | – | ﹤0.01% | 4467 |
|
|
2022
Q4 | $1.03K | Hold |
207
| – | – | ﹤0.01% | 4400 |
|
|
2022
Q3 | $1K | Hold |
207
| – | – | ﹤0.01% | 4373 |
|
|
2022
Q2 | $1K | Sell |
207
-12
| -5% | -$52 | ﹤0.01% | 4398 |
|
|
2022
Q1 | $1K | Buy |
219
+127
| +138% | +$703 | ﹤0.01% | 4426 |
|
|
2021
Q4 | $1K | Buy |
+92
| New | +$572 | ﹤0.01% | 4354 |
|
|
2020
Q3 | – | Sell |
-355
| Closed | -$2K | – | 4085 |
|
|
2020
Q2 | $2K | Sell |
355
-123
| -26% | -$523 | ﹤0.01% | 3805 |
|
|
2020
Q1 | $2K | Sell |
478
-631
| -57% | -$2.76K | ﹤0.01% | 3765 |
|
|
2019
Q4 | $6K | Buy |
1,109
+781
| +238% | +$2.65K | ﹤0.01% | 3639 |
|
|
2019
Q3 | $1K | Buy |
328
+67
| +26% | +$178 | ﹤0.01% | 3949 |
|
|
2019
Q2 | $1K | Hold |
261
| – | – | ﹤0.01% | 3971 |
|
|
2019
Q1 | $1K | Hold |
261
| – | – | ﹤0.01% | 3983 |
|
|
2018
Q4 | $1K | Buy |
261
+36
| +16% | +$218 | ﹤0.01% | 3993 |
|
|
2018
Q3 | $2K | Hold |
225
| – | – | ﹤0.01% | 3980 |
|
|
2018
Q2 | $2K | Sell |
225
-124
| -36% | -$1.31K | ﹤0.01% | 4005 |
|
|
2018
Q1 | $4K | Sell |
349
-33
| -9% | -$326 | ﹤0.01% | 3948 |
|
|
2017
Q4 | $2K | Sell |
382
-1,125
| -75% | -$6.94K | ﹤0.01% | 4030 |
|
|
2017
Q3 | $12K | Sell |
1,507
-100
| -6% | -$664 | ﹤0.01% | 3622 |
|
|
2017
Q2 | $12K | Buy |
1,607
+157
| +11% | +$718 | ﹤0.01% | 3531 |
|
|
2017
Q1 | $5K | Sell |
1,450
-1,806
| -55% | -$5.27K | ﹤0.01% | 3754 |
|
|
2016
Q4 | $6K | Sell |
3,256
-1,490
| -31% | -$2.99K | ﹤0.01% | 3649 |
|
|
2016
Q3 | $12K | Sell |
4,746
-531
| -10% | -$1.54K | ﹤0.01% | 3432 |
|
|
2016
Q2 | $16K | Sell |
5,277
-2,927
| -36% | -$18.4K | ﹤0.01% | 3371 |
|
|
2016
Q1 | $71K | Buy |
8,204
+2,414
| +42% | +$20.4K | ﹤0.01% | 2660 |
|
|
2015
Q4 | $78K | Sell |
5,790
-161
| -3% | -$1.98K | ﹤0.01% | 2599 |
|
|
2015
Q3 | $57K | Sell |
5,951
-2,464
| -29% | -$36K | ﹤0.01% | 2820 |
|
|
2015
Q2 | $120K | Buy |
8,415
+1,280
| +18% | +$14.1K | ﹤0.01% | 2530 |
|
|
2015
Q1 | $64K | Buy |
7,135
+2,395
| +51% | +$17.3K | ﹤0.01% | 2919 |
|
|
2014
Q4 | $29K | Buy |
4,740
+440
| +10% | +$4.02K | ﹤0.01% | 3011 |
|
|
2014
Q3 | $45K | Sell |
4,300
-865
| -17% | -$9.79K | ﹤0.01% | 2729 |
|
|
2014
Q2 | $62K | Hold |
5,165
| – | – | ﹤0.01% | 2498 |
|
|
2014
Q1 | $76K | Buy |
5,165
+365
| +8% | +$5.75K | ﹤0.01% | 2333 |
|
|
2013
Q4 | $70K | Sell |
4,800
-500
| -9% | -$7.68K | ﹤0.01% | 2360 |
|
|
2013
Q3 | $89K | Sell |
5,300
-33
| -0.6% | -$580 | ﹤0.01% | 2238 |
|
|
2013
Q2 | $88K | Buy |
+5,333
| New | +$86.4K | ﹤0.01% | 2171 |
|
Other funds holding IMGN
PNC Financial Services Group's IMGN Position: Q1 2024 in Review
PNC Financial Services Group sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 611 shares — an estimated $18.1K sold.
PNC Financial Services Group first reported a position in IMGN in Q2 2013 and held it in 38 quarters. The position peaked at $120K in Q2 2015. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.
- PNC Financial Services Group reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
- PNC Financial Services Group sold 611 Immunogen Inc shares in Q1 2024, an estimated $18.1K.
- PNC Financial Services Group first reported a position in Immunogen Inc in Q2 2013 and held it in 38 quarters.
- PNC Financial Services Group's Immunogen Inc position peaked at $120K in Q2 2015.
- 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.
Based on PNC Financial Services Group's 13F filing for Q1 2024, filed 10 May 2024.